Evidence map›Paper›PMID 35106836›Full record

ArticleMovement disorders : official journal of the Movement Disorder Society2022

Assessment of Glucocerebrosidase Enzyme Activity in Parkinson Disease Using Multiple Approaches.

Roberto A Ortega, Olaf Bodamer, Roy W A Peake, Deborah Raymond, Susan B Bressman, Rachel Saunders-Pullman

Abstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Movement disorders : official journal of the Movement Disorder Society, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Roberto A OrtegaDepartment of Neurology, Mount Sinai Beth Israel, and Icahn School of Medicine, New York, New York, USA.ORCID 0000-0002-8044-3340
Olaf BodamerDivision of Genetics and Genomics, Department of Medicine, Boston Children's Hospital, Boston, Massachusetts, USA.
Roy W A PeakeDepartment of Laboratory Medicine, Boston Children's Hospital, Boston, Massachusetts, USA.
Deborah RaymondDepartment of Neurology, Mount Sinai Beth Israel, and Icahn School of Medicine, New York, New York, USA.
Susan B BressmanDepartment of Neurology, Mount Sinai Beth Israel, and Icahn School of Medicine, New York, New York, USA.
Rachel Saunders-PullmanDepartment of Neurology, Mount Sinai Beth Israel, and Icahn School of Medicine, New York, New York, USA.

Funding

Genetic Analysis and Manipulation Core (GAEC)P50HD105351 · NICHD · BOSTON CHILDREN'S HOSPITAL · PI SCOTT Loren POMEROY, MUSTAFA SAHIN · 2021 to 2026
$9.4M
Dissecting Oligogenic Biomarkers in Ashkenazi Jews with Parkinson DiseaseU01NS107016 · NINDS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI OZELIUS, LAURIE J., SAUNDERS-PULLMAN, RACHEL · 2019 to 2023
$6.6M
Evaluation of glucocerebrosidase pathway biomarkers in Parkinson DiseaseU01NS094148 · NINDS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI KRAINC, DIMITRI, SAUNDERS-PULLMAN, RACHEL · 2015 to 2017
$1.4M
NICHD NIH HHS P50 HD105351NINDS NIH HHS U01 NS094148NINDS NIH HHS U01 NS107016
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Gaucher DiseaseParkinson Diseasealpha-SynucleinGlucosylceramidaseHumansalpha-SynucleinGlucosylceramidase

Identifiers

PMID35106836
PMCPMC9948675

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.